Can sensitivity of voided urinary cytology or bladder wash cytology be improved by the use of different urinary portions?

Urologia Internationalis

Volumn 62, Issue 4, 1999, Pages 209-212

  Mungan, N Aydin ^a,b   Kulacoglu, Sezer ^a   Basar, Murat ^a   Sahin, Mehmet ^a   Witjes, J Alfred ^b  

^a ANKARA NUMUNE HOSPITAL   (Turkey)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Cytology; Sensitivity; Superficial bladder cancer

Indexed keywords

ADULT; AGED; ARTICLE; BLADDER CANCER; BLADDER IRRIGATION; CANCER STAGING; DIAGNOSTIC ACCURACY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; TRANSITIONAL CELL CARCINOMA; URINE CYTOLOGY;

CARCINOMA, TRANSITIONAL CELL; FEMALE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; URINARY BLADDER NEOPLASMS; URINE;

EID: 0032742196     PISSN: 00421138     EISSN: None     Source Type: Journal    
DOI: 10.1159/000030397     Document Type: Article

References (24)

1. Matzkin H, Moinuddin SM, Soloway MS: Value of urine cytology versus bladder washing in bladder cancer. Urology 1992;39:201-203.
2. Soloway MS: Initial evaluation and response criteria for patients with superficial bladder cancer; report of a workshop. Br J Urol 1990; 66:380-385.
3. Murphy WM: Current status of urinary cytology in the evaluation of bladder neoplasms. Hum Pathol 1990;21:886-896.
4. Sherman AB, Koss LG, Adams SE: Intraobserver differences in the diagnosis of urethelial cells: Comparison with classification by computer. Anal Quant Cytol Histol 1984;6:112-118.
5. Badalament RA, Hermansen DK, Kimmel M, Gay H, Her HW, Fair W: The sensitivity of bladder wash cytometry, bladder wash cytology and voided cytology in detection of bladder carcinoma. Cancer 1987;60:1423-1427.
6. Ro JR, Staerkel GA, Ayala AG: Cytologic and histologic features of superficial bladder cancer. Urol Clin North Am 1992;19:435-453.
7. Murphy WM, Soloway MS, Jukkola AF, Crabtree WN, Ford KS: Urinary cytology and bladder cancer: The cellular features of transitional cell neoplasms. Cancer 1984;53:1555-1565.
8. Gammarra MC, Zein T: Cytologic spectrum of bladder cancer. Urology 1984;23(suppl):23-26.
9. Freidell GH, Hawkins IR, Ahmcd SW, Schmidt JD: The role of urinary tract cytology in the detection and clinical management of bladder cancer; in Bladder cancer. American Urological Association Monographs. Baltimore, Williams & Wilkins, 1982.
10. Jocham D, Gottinger H, Schiedt E: Stellenwert der Urinzytologie in der urologischen Diagnostik: Ein 10-Jahres-Bericht. Urologe [A] 1982; 21:79-83.
11. Wiener HG, Vooijs GP, Hof-Grootenboer B: Accuracy of the urinary cytology in the diagnosis of primary and recurrent bladder cancer. Acta Cytol 1993;37:163-169.
12. Murph WM: Flow cytometry versus urinary cytology in the evaluation of patients with bladder cancer. J Urol 1986;136:815-819.
13. Badalament RA, Fair WR, Whitmore WF, Mclamed MR: The relative value of cytometry and cytology in the management of bladder cancer: The Memorial Sloan-Kettering Cancer Center experience. Semin Urol 1988;6:22-27.
14. Harris MF: Exfoliate cytology of the urinary bladder irrigation specimen. Acta Cytol 1971; 15:385-389.
15. Zein T, Waisman Z, Englander ES, Gammarra MC, Eopez C, Huben RP: Evaluation of bladder washings and urinary cytology in the diagnosis of bladder cancer and its correlation with selected biopsies of the bladder mucosa. J Urol 1984;132:670-671.
16. Aamodt RE, Coon JS, Deitch A, de Vere-White RW, Koss LG, Melamed MR: Flow cytometric evaluation fo bladder cancer: Recommendations of NCI flow cytometry network for bladder cancer. World J Urol 1992;10:63-67.
17. Murphy WM, Crabtree WN, Jukkola AF, Soloway MS: The diagnostic value of urine versus bladder washing in the patients with bladder cancer. J Urol 1981;126:320-326.
18. Sarosdy MF, de Vere-White RW, Soloway MS, Scheinfeld J, Hudson MA, Schellhammer PF: Results of multicenter trail using the BTA test to monitor for and diagnose recurrent bladder cancer. J Urol 1995;154:379-384.
19. Sarosdy MF, Hudson MA, Ellis WJ, Soloway MS, de Vere-White R, Scheinfeld J, Jarowenko MV, Schellhammer PF, Schervish EW, Patel JV, Chodak GW, Lamm DL, Johnson RD, Handerson M, Adams G, Blumenstein BA, Thoelke KR, Pfalzgraf RD, Murchison HA, Brunelle SL: Improved detection of recurrent bladder cancer using the Bart BTA stat test. Urology 1997;50:349-353.
20. National Bladder Cancer Collaborative Group A: Cytology and histopathology of bladder cases in prospective longitudinal study. Cancer Res 1977;37:2911-2918.
21. Van der Poel HG, van Balken MR, Schamhart HJ, Peelen P, de Reijke TH, Debruyne FMJ, Schalken JA, Witjes JA: Bladder wash cytology, quantitative cytology, and the qualitative BTA test in patients with superficial bladder cancer. Urology 1988;51:44-50.
22. Van der Poel HG, Witjes JA, van Stratum ME, Boon ME, Debruyne FMJ, Schalken JA: Quanticyt: Karyometric analysis of bladder washing for patients with superficial bladder cancer. Urology 1996;48:357-364.
23. Ianari A, Sternberg N, Rosetti A, Van Rijn A, Deidada A, Giannerelli D: Results of Bard BTA test in monitoring patients with a history of transitional cell cancer of the bladder. Urology 1997;49:786-789.
24. D'Hallewin MA, Baert L: Initial evaluation of the bladder tumor antigen test in superficial bladder cancer. J Urol 1996;155:475-476.